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Summary: Using a commercially aVailable test for LDL cholesterol (Boehringer Mannheim), a method was
developed for determination of LDL apolipoprotein B without using Ultracentrifugation. The infranatant
obtained by precipitätion of serum with polyvinylsulphate was redissolved in a saline citrate solution and
incubated with phospholipase A2, phpspholipase C, phospholipase D or triglyceride lipase, respectively. When
the saline-citrate redissolved precipitate was monitored by electron microscopy, it appeared äs a fibriform
network. The additionäl incübation with phospholipase A2, C, D, or triglyceride lipase resulted in a
molecularization of LDL particles. By electron micröscopy these particles could not be distinguished from
LDL particles isolated by Ultracentrifugation. In radial immunodiffusion tests, the additionäl incübation of
the redissolved precipitate with phospholipase C or phospholipase D resulted in a total loss of the slight
iitimunoreactivity observed before phospholipase incübation. However, additionäl incübation with triglyceride
lipase resulted in a significant increase in immunoreactivity. Only the additionäl incübation of the redissolved
precipitate with phospholipase A2 resulted in an immunoprecipitation reaction comparable to that with LDL
particjes isolated by Ultracentrifugation. Using a resolubilized and phospholipase A2-incubated precipitate
of a pool serum äs apolipoprotein B Standard, a good correlation was obtained between apolipoprotein B
values measured in this dissolved precipitate and those meäsured in the d > 1.006 kg/l fraction isolated by
Ultracentrifugation (r = 0.95; y = 0.95x + 0.018; n = 44).
Apolipoprotein B-Bestimmung im Präzipitat nach Fällung von LDL mit Polyvinylsulfat
Eine alternative Methode zur Bestimmung von LDL-Apolipoprotein B ohne Ultrazentrifugation
Zusammenfassung: Auf der Basis eines kommerziell erhältliehen Tests zur LDL-Cholesterinbestimmung
(Boehringer-Mannheim) wurde eine Methode zur Bestimmung von LDL-Apolipoprotein B ohne Ultrazentri-
fugation entwickelt.
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Das nach Fällung von Seren mit Polyvinylsulfat auftretende Präzipitat wurde in Natriumchlorid-Citratlösung
aufgelöst und in Gegenwart von Phospholipase A2, Phospholipase C, Phospholipase D oder Triglyceridlipase
inkubiert. Das mit Natriumchlorid-Citratlösung aufgelöste Präzipitat zeigte elektronenmikroskopisch ein
fibriformes Netzwerk. Die zusätzliche Inkubation mit Phospholipase A2, C, D oder Triglyceridlipase bewirkte
eine Rekonstitution der LDL-Partikel. Elektronenoptisch waren diese Partikel nicht von LDL-Partikeln zu
unterscheiden, die durch Ultrazentrifugation isoliert wurden. Die zusätzliche Inkubation der aufgelösten
Präzipitate mit Phospholipase C oder Phospholipase D führte zu einem vollständigen Verlust der Immunreak-
tivität bei Durchführung der radialen Immundiffusion, während die zusätzliche Inkubation mit Triglyceridli-
pase eine leichte Steigerung der Immunreaktivität ergab. Die zusätzliche Inkubation der aufgelösten Präzipi-
tate mit Phospholipase A2 bewirkte dagegen eine Immunpräzipitation, die derjenigen von durch Ultrazentrifu-
gation isolierten LDL-Partikeln entsprach.
Der Vergleich der Apolipoprotein B-Werte im aufgelösten Präzipitat mit denen der durch Ultrazentrifugation
isolierten d > 1,006 kg/l Fraktion ergab eine Übereinstimmung der Wertepaare, wenn als Standard ein
aufgelöstes und Phospholipase A2-behandeltes Polyvinylsulfat-Präzipitat eines Poolserums verwandt wurde
(r = 0,95, y = 0,95x + 0,018, n = 44).
Introduction
Previous epidemiological studies have shown that an
elevated concentration of LDL cholesterol represents
a risk factor for coronary heart disease (1—2). But
LDL are not homogeneous; rather, they comprise a
relatively heterogeneous group of particles of which
apolipoprotein B, in particular, is the marker by
which peripheral and hepatic receptors recognize
LDL particles (3). Because of the key role of apolipo-
protein B in LDL metabolism it may be, theoretically,
a better predictor of coronary heart disease than LDL
cholesterol (4). The accurate determination of LDL
apolipoprotein B, however, implies a time-consuming
Isolation of LDL by ultracentrifugation. Recently,
Sniderman et al. (4) have measured apolipoprotein B
levels in LDL separated from VLDL by exclusive gel
radial immunodiffusion. However, the accuracy of
this method may be limited because small VLDL
particles may interfere with the determination of LDL
apolipoprotein B.
In the present paper we describe a new method for
determination of LDL apolipoprotein B. The method
is based on the selective precipitation of LDL from
whole serum .with polyvinylsulphate (5), using a re-





LDL cholesterol precipitant reagent, containing l g/l polyvinyl-
sulphate, 169 g/l polyethyleneglycol methylether and 5 mmol/1
Na2 EDTA (catalogue No. 726290), phospholipase A2 (EC
3.1.1.4 (6000 kU/1), order No. 161454), phospholipase C (EC
3.1.4.3 (1600 kU/1), order No. 108502), phospholipase D (EC
3.1.4.4 (50 kU/1), order No. 108537), and "test combination
Triglyceride vollenzymatisch UV Test" (order no. 240052) were
purchased from Boehringer Mannheim, D-6800 Mannheim 31,
FRG.
Immunoscieiitific Anti-apo B (order No. 4834005) was obtained
from Immuno AG, Vienna, Austria, apolipoprotein B Standard
serum (order No. OTRF 02/03) from Behfingwefke AG, D-
3550 Marburg, FRG.
Servablue R was obtained from Serva, D-6900 Heidelberg,
FRG, and triglyceride lipase (1.0 kU/ml, order No. 437611)
from Calbiochem, Behring Corp., La Jolla, CA 92037, USA.
Tris-barbital-lactate buffer, pH(8.6, contained 0.366 inol/1 Tris,
0.120 mol/1 barbituric acid, 15.2 nönol/1 Na azide, 1.68 mmol/1
Ca lactate. For radial immunodiffusion assay this buffer was
diluted l : 8 with distilled water.
Thesit (dodecyl alcohol polyoxyethylene ether) was obtained
from Desitin-Werke, C. Klinke GmbH, D-2000 Hamburg,
FRG, Apovax from Ortho Diagnostic, Belgium and Triton -
00 from Sigma Chemie GmbH, D-8028 Taufkirchen, FRG.
Sample material
As test material we used fresh serum from the test series
"Prospective epidemiological study in Company employees in
Westphalia" (6).
Procedures
Precipitation of LDL with polyvinylsulphate
Precipitation of LDL with polyvinylsulphate was performed äs
previously described (5). For the LDL precipitation 100
serum were mixed in an incubation tube (Sarsted No. 52690)
with 50 precipitation reagent, left at room temperature for
15 minutes and centrifuged in an Eppendorf Centrifuge 3200
fof 2 x 2 minutes. The precipitate obtained by carefül and
complete decantation of the supernatant was resölubilized with
600 ul of a solution contaming 0.15 mol/1 trisodiüm citrate and
0.11 mol/1 sodium Chloride and mixed thoroughly with a vortex
for 2 4 minutes. * *
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Incubation of resolubilized polyvinylsulphate-induced precipitate
with lipases
Dissolved precipitate (100 μΐ) was thoroughly mixed with 6 μί
phospholipase A2 or 10 μΐ phospholipase C, or 100 μΐ phospho-
lipase D, or 100 μΐ triglyceride lipase, respectively (7). The
mixture was incubated at 40 °C (phospholipase A2) or 37 °C
(phospholipase C, phospholipase D, triglyceride lipase) for
6 — 24 hours, followed by deterrnination of apolipoprotein B.
Determination of apolipoprotein B by radial immunodiffusion
RID was performed according to Mancini et al. (8). Anti-
apolipoprotein-B (40 μί) was mixed with 20 ml of l % solution
of agarose in Tris-barbital-lactate buffer pH 8.6. The volume
of the sample was 5 μί. Apolipoprotein B Standard serum was
diluted with 0.15 mol/1 NaCl 1:2, 1:4, 1:8, l : 16, l : 32.
Incubation time was 4 days at room temperature. The diameters
of the precipitation rings obtained were measured following
staining with Servablue R.
Preparative Isolation of lipoproteins by ultracentrifugation
Preparative isolation of lipoproteins by ultracentrifugation was
performed s previously described (9).
Negative staining and electron microscopy
Negative staining for electron microscopy was performed by
placing a formvar-coated grid for 5 minutes on a drop of
diluted solution of lipoproteins, which was then transferred to
a drop of distilled water for l minute and fmally to a drop of
20 g/l uranyl acetate, pH 3.5, for 5 minutes. The grids were
examined in a Philips EM 201 operated at 60 kV.
Results
Influence of phospholipases and detergents on the con-
stitution of LDL p rticles in the precipitate obtained
after addition of polyvinylsulphate to serum
Figure l shows an electron micrograph of the
d 1.006^1.063 kg/l fraction isolated by ultracentrifu-
gation. The fraction consists of homogeneous and
monodispersed p rticles with mean diameter of 20.7
nm (fig. la). In contrast to the d 1.006 — 1.063 kg/l
fraetion, the electron microscopy of a precipitate dis-
solved in citrate saline solution shows an heterogen-
eous and fibrillar network lackirig monodispersed
partrcles (fig. Ib). The addition of each of the deter-
gents Thesit (1.0%), Triton X-100 (l.0%) and Apovax
(1,0%) did not result in a reconstit tion of lipoprotein
p rticles visible by electron microscopy. However,
incubation of the precipitate with phospholipase A2
(340 kU/1 final concentration) fpr more than 6 hours
at 40 °C res lted in a reconstit tion of lipoprotein
p rticles (fig. Ic). The phospholipase A2-treated pre-
cipitate consists of monodispersed and homogeneous
p rticles with a mean diameter of 20.8 nm. By elec-
tron microscopy these Upoprotein p rticles were in-
Fig. 1. a) Electron micrograph of the d 1.006 — 1.063 kg/l frac-
tion isolated by ultracentrifugation.
b) Electron micrograph of the polyvinylsulphate-in-
duced precipitate dissolved in citrate saline solution.
c) Electron micrograph of the redissolved polyvinylsul-
phate-induced precipitate incubated with phospho-
lipase A2 (340 kU/1 final concentration) for 6-24 h
at 40 °C. Bar: 9.5 nm.
distinguishable from p rticles obtained by ultracen-
trifugation. Similar results were obtained by using
triglyceride lipase (500 kU/1 final concentration) or
other lipases like phospholipase C (145.5 kU/1 final
concentration) and phospholipase D (25 kU/1 final
concentration).
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Influence of phospholipases and triglyceride lipase on
the diameter of the precipitation rings using radial
immunodiffusion (RID)
In the RID only small precipitation rings were ob-
tained when the precipitate dissolved in citrate saline
solution was used s the sample (fig. 2). The addi-
tional incubation of the dissolved precipitate with
phospholipase C (145.5 kU/1 final concentration) or
phospholipase D (25 kU/1 final concentration) elimin-
ated any visible immunoprecipitation. The additional
incubation of the dissolved precipitate with triglycer-
ide lipase (500 kU/1 final concentration), however,
resulted in enhanced immunoprecipitation. A further
increase of added triglyceride lipase > 500 kU/1 final
concentration caused no enhancement of the dia-
meter of the precipitation rings. Incubation of the
dissolved precipitate with phospholipase A2 (340 kU/1
final concentration) resulted in a major enhancement
of the immunoreaction exceeding that of lipase incu-
bation. Optimal conditions were found when phos-
pholipase A2 was incubated at a final concentration
of 340 kU/1 for 6 h at 40 °C.
Influence offreezing on the immunoprecipitation
When dissolved and phospholipase A2-incubated pre-
cipitates were stored for 6 months at —20 °C, ident-
ical values were obtained when compared with dis-
solved and phospholipase A2-incubated precipitates
from the fresh samples.
Precision of apolipoprotein B determination of the dis-
solved polyvinylsulphate induced precipitates
With regard to the precision in series, a Variation
coefficient of 6% (n = 15; χ = 1.0 g/l) was obtained.
Day to day precision (8%; n = 15; χ = 0.95 g/l) was
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Fig. 2. Influence of the additional incubation of the dissolved
polyvinylsulphate-induced precipitate with phospho-
lipase A? (340 kU/1), phospholipase C (145.5 kU/1),
phospholipase D (25 kU/1) and triglyceride lipase (500
kU/1) on the square diameters of the precipitation rings
using radial immunodiffusion.
c —o phospholipase A2
o —o phospholipase C
Δ — Δ no addition of enzyines
χ - χ triglyceride lipase
^ — ̂  phospholipase D.
kg/l fraction using a commercially available apolipo-
protein B Standard serum (Behring Werke AG) s
reference material. Comparison of the apolipoprotein
B values measured in the dissolved precipitate of
normo- and hypertriglycerid emic sera (0.46 — 8.55
mmol/1 triglycerides) with the corresponding apolipo-
protein B values measured in the d > 1.006 kg/l
fraction, showed a good correlation (r = 0.95;
y = 0.95 χ + 0.018; n = 44) (fig. 3). The mean value
obtained from the dissolved precipitate (y = 0.607)
was nearly identical to the inean value obtained by
the reference method (x = 0.616).
Accuracy of apolipoprotein B determination in dis-
solved precipitates
The accuracy of the apolipoprotein B measurements
in dissolved precipitates was determined by compari-
son with corresponding apolipoprotein B values
measured in the d > 1.006 kg/l fraction isolated by
ultracentrifugation. As the Standard for apolipopro-
tein B determination in dissolved precipitates, we
used a resolubilized and phospholipase A2-incubated
precipitate of a pool serum. The apolipoprotein B
.concentration of this tertiary Standard was deter-
mined by RID s apolipoprotein B in the d > l .006
Discussion
In previous. studies we have shown that the addition
of polyvinylsulphate to serum in different conceatra-
tions resulted in a complete precipitation of LDL and
Lp(a) without co-precipitation of VLDL and HOL
(5). The simultaneous addition of polyethyleneglycol
methylether is necessary, in order to qbtain complete
and selective precipitation of LDL with polyvinylsul-
phate. Polyethyleneglycol methylether is supposed to
remoye the hydration layer of LDL, so that biiiding
of polyvinylsulphate to LDL particles is strengthened
(Ziegenhorn, J. & Draeger, R:j unpublished). The
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Fig. 3. Regression analysis of apolipoprotein B values meas-
ured in the phospholipase A2-incubated polyvinylsul-
phate-induced precipitate (y) and apolipoprotein B va-
lues measured in the d > 1.006 kg/l ultracentrifugation
fraction (x) of normo- and hypertriglyceridaemic sera
(0.46—8.45 mmol/1 triglycerides).
r = 0.95; y = 0.95x + 0.018; n = 44.
polyvinylsulphate precipitation method described is
in principle a further development of former precipi-
tation techniques, which used polysaccharides such äs
amylopectin or dextran sulphate (10). These previous
studies have shown that complete precipitation and
reproducibility of results depend on the degree of
Polymerisation and the sulphate content per mono-
mer of the polysaccharides used. In synthetic structu-
res, a defined sulphate Content per monomer, äs well
äs a constant degree of polymerisation, can be obtain^
ed.
The sulphate groups of polyvinylsulphate are
supposed to aggregate with the positively-charged
basic LDL particles (Ziegenhorn, J. & Draeger, B.,
unpublished), Furthermore, it has been supposed that
in addition to ionogenic binding, pH-independent
hydrophobic interactions are involved. 'As shown by
electron microscopy, the precipitation of LDL by
polyvinylsulphate resulted in a masking of the typical
structure of LDL particles. However, the original
structure of monodispersed LDL particles does not
seem to be destroyed by polyvinylsulphate precipita-
tion. The cleavage of phospholipids by phospholipase
A2, C or D respectively, äs well äs the addition of
triglyceride lipase resulted in the reappearance of
lipoprotein particles which could not be distinguished
from native LDL particles isolated by ultracentrifu-
gation. As shown by Nishida (11), phospholipase A
treatment of insoluble complexes obtained after addi-
tion of dextran sulphate to LDL also resulted in
the production of soluble and deaggregated LDL
complexes. This result suggests that fatty acids caused
the formation of soluble complexes by the association
of negatively charged fatty acids with the lipoprote-
ins. Possibly, Charge interactions are of importance
in the resolution of insoluble LDL polyanion com-
plexes.
It has been shown (12) that the incubation of LDL
particles isolated by ultracentrifugation with phos-
pholipase A2 does not affect the composition or the
electron microscopic structure of the LDL particles.
Furthermore, the immunoreactivity of LDL is not
influenced by the phospholipase A2 treatment of
LDL. In our experiments the addition of phospho-
lipase A2 resulted in an increase of immunoreactivity
of apolipoprotein B in dissolved polyvinylsulphate,
äs compared to untreated, dissolved precipitates.
Apparently, the increase in the immunoreactivity of
the phospholipase A2-treated, redissolved precipitates
reflects a "normalization" of immunoreactivity of
particle-bound apolipoprotein B. However, the clea-
vage of the phosphorylcholine or choline components
of choline-containing phospholipids resulted in a to-
tal disappearance of the immunoreactivity of lipo-
protein-bound apolipoprotein B. Possibly, the phos-
pholipase C and phospholipase D treatment altered
the conformation of apolipoprotein B? so that the
immunoreaction was inhibited.
Our results show that the method described can be
used for routine determination of LDL apolipopro-
tein B. However, LDL fractions isolated by ultracen-
trifugation caniiot be used äs Standards, since there
is a difference in the immunoreactivity between LDL
fractions isolated by ultracentrifugation and those
isolated with polyvinylsulphate. The problem can be
solved by using phospholipase A2-treated, dissolved
precipitate äs a Standard, and determination of apoli-
poprotein B in the d> 1006 kg/l fraction of the same
serum. According to our results, phospholipase A2-
incubated dissolved precipitate can be refrigerated
with no change in immunoreactivity. The coprecipita-
tion of Lp(a) may be a disadvantage for the accurate
determination of LDL apolipoprotein B using the
method described. In sera containing Lp(a) values
< 0.10 g/l (total Lp(a) mass measured by rocket
electrophoresis (13)), Lp(a) apolipoprotein B does
not have to be taken into account. In sera containing
Lp(a) concentrations > 0.10 g/l, the LDL apolipo-
protein B values should be calculated by appropriate
corrections (Lp(a) contains approximately 18% apo-
lipoprotein B related to total Lp(a) mass) (14).
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